Medical Advocates
Indinavir (Crixivan)
 
Pediatric Data

US Treatment Guidelines
General Reports
 Pharmacokinetics
 Monotherapy
 Combination Therapy
 Switching Drugs
 Therapeutic Drug Monitoring

 

 
Indinavir Main Page Main New/Newsworthy Home Page      
Last Update:  September 18, 2007
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Prevention/Treatment Guidelines and Recommendations
United States      


USPHS Pediatric Antiretroviral Drug Information
 (Effective March 24, 2005) 

 
General Reports
       

        Journal Papers, Abstracts, and Commentaries

  Changes in indinavir exposure over time: a case study in six HIV-1-infected children.
Fraaij PL, Bergshoeff AS, Van Rossum AM ,et al 
J Antimicrob Chemother. 2003 Oct;52(4):727-30.
Abstract
Pharmacokinetics
 

          Journal Papers, Abstracts, and Commentaries

 
Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human
Immunodeficiency Virus Type 1-Infected Children.
 Bergshoeff AS, Fraaij PL, Van Rossum AM, et al 
Antimicrob Agents Chemother. 2004 May;48(5):1904-1907.
 Abstract

FULL-TEXT ARTICLE
 Indinavir pharmacokinetics and pharmacodynamics in children with human
immunodeficiency virus infection.
Gatti G, Vigano' A, Sala N, Vella S, et al.
Antimicrob Agents Chemother 2000 Mar;44(3):752-755
 Paper
   
  FULL-TEXT ARTICLE
Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus
type 1-infected children.
Burger DM, van Rossum AMC, Hugen PWH, et al
 Antimicrobial Agents and Chemotherapy 2001; 45:701-705. 
Paper
   
  Long-term virologic and immunologic responses in human immunodeficiency virus type
1-infected children treated with indinavir, zidovudine and lamivudine.
Jankelevich S, Mueller BU,Mackall CL, et al
Journal of Infectious Disease 2001; 183:1116-1120. 
 Abstract
Adverse Events
 

             Conference Reports, Abstracts and Posters

Hyperbilirubinemia in children treated with Indinavir
FE Eseme, C Giaquinto, E Ruga, et al
 (14IAC)
 Abstract
Monotherapy
 

             Journal Papers, Abstracts, and Commentaries

  A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
Mueller BU, Sleasman J, Nelson RP et al
Pediatrics 1998; 102 (1 Pt 1): 101-109.
 Abstract
Combination Therapy
 

IND/RTV

             Journal Papers, Abstracts, and Commentaries

 
Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent
Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation
of Treatment.
 Fraaij PL, Verweel G, van Rossum AM, et al
Infection. 2007 Jun;35(3):186-9.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Efficacy and Plasma Concentrations of Indinavir when Boosted with Ritonavir in HIV-Infected
Thai Children
 Plipat N, Cressey TR, Vanprapar N, Chokephaibulkit K.
Pediatr Infect Dis J. 2007 Jan;26(1):86-88
 Abstract

Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human
Immunodeficiency Virus Type 1-Infected Children.
 Bergshoeff AS, Fraaij PL, Van Rossum AM, et al 
Antimicrob Agents Chemother. 2004 May;48(5):1904-1907.
 Abstract

          Conference Reports, Abstracts and Posters

 
Efficacy and plasma drug levels of indinavir when either boosted with 100 mg or with full
dose ritonavir in HIV-infected Thai children
 Plipat N., Cressey T.R., Vanprapar N., Chokephaibulkit K.
(XVI International AIDS Conference)
 Abstract

Indinavir/ritonavir in HIV - infected children
G Jugulete, M I Dragan, M Mardarescu, S Petrea
 (14IAC)
 Abstract

IND/STV/DDI

             Journal Papers, Abstracts, and Commentaries

  A pilot study of combination therapy with indinavir, stavudine (d4T), |and didanosine
(ddI) in children infected with the human immunodeficiency virus.
Journal of Pediatrics1 998; 132(3 Pt 1): 543-546.
Abstract
   
  FULL-TEXT ARTICLE
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human
immunodeficiency virus-infected children receiving combination therapy.
Fletcher CV, Brundage RC, Remmel RP et al
Antimicrobial Agents and Chemotherapy 2000; 44(4): 1029-1034.
 Paper

IND/STV/3TC

           Journal Papers, Abstracts, and Commentaries

  Clinical and virologic response to combination treatment with indinavir, zidovudine,
and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter
study in The Netherlands.
van Rossum AMC, Niesters HGM, Geelen SPM, et al.
Journal of Pediatrics 2000; 136:780-788.  
Abstract
   
  Clinical and immuno-virological characterization of the efficacy of stavudine,
lamivudine and indinavir in human immunodeficiency virus infection.
Vigano A, Dally L, Bricalli D, et al.
Journal of Pediatrics 1999; 135(6): 675-82.
Abstract

IND/ZDV/3TC

         Journal Papers, Abstracts, and Commentaries

  Long-term virologic and immunologic responses in human immunodeficiency virus
type 1-infected children treated with indinavir, zidovudine, and lamivudine.
Jankelevich S, Mueller BU, Mackall CL,
Infect Dis. 2001 Apr 1;183(7):1116-20.
 Abstract

Multiple Combinations

         Journal Papers, Abstracts, and Commentaries

  Comparison of two antiretroviral triple combinations including the rotease inhibitor
 indinavir in children infected with human immunodeficiency virus.
Wintergerst U, Hoffmann F, Solder B, et al.
Pediatric infectious Disease Journal 1998; 17:495-499. 
Abstract
Switching Drugs
 

             Journal Papers, Abstracts, and Commentaries

  Switch from Ritonavir to Indinavir in Combination Therapy for HIV-1-Infected Children.
 Pelton SI, Stanley K, Yogev R, et al
Clin Infect Dis. 2005 Apr 15;40(8):1181-7
 Abstract
Therapeutic Drug Monitoring
 

          Conference Reports, Abstracts and Posters

  Therapeutic drug monitoring of indinavir boosted with ritonavir in
pediatric patients
Curras V., Höcht C., Bramuglia G., et al
 (3rd IAS Conference)
 Abstract

 
Indinavir Main Page Main New/Newsworthy Home Page      

Indinavir Pediatric Data